Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales.
Melia
Jane
J
Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK.
D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003657:Decision Making; D018450:Disease Progression; D042241:Early Diagnosis; D004739:England / Q000453:epidemiology; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D010375:Pedigree; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality; D012017:Referral and Consultation; D016019:Survival Analysis; D015996:Survival Rate; D013997:Time Factors; D014852:Wales / Q000453:epidemiology
D017430:Prostate-Specific Antigen